Gupta, N., Manirambona, L., Shumbusho, F., Kabihizi, J., Murangwa, A., Serumondo, J., Makuza, J. D., Nsanzimana, S., Muvunyi, C. M., Mukabatsinda, C., Musabeyezu, E., Camus, G., Grant, P. M., & Kateera, F. (2022). safety and efficacy of sofosbuvir–velpatasvir–voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial. Lancet gastroenterology and hepatology, 7, 542–551. http://access.bl.uk/ark:/81055/vdc_100155025268.0x000003